Management of Depression Refractory to First-Line Therapies Micro-Learning Flight

Expert insights from an interdisciplinary team of psychiatry-trained palliative care physicians and pharmacy will discuss cross-tapering, medication augmentation, Ketamine, and Electroconvulsive therapy (ECT) therapeutic strategies for patients experiencing depression who do not benefit from initial antidepressant trails. 

Depression is common among people with serious illnesses. Palliative care clinicians routinely manage depression as part of comprehensive serious illness care. Although pharmacological interventions comprise first-line therapy for patients with moderate or worse depression, around half of patients do not respond to initial medications. A range of strategies exist for patients with depression who do not benefit from initial antidepressant trial. However, some clinicians may feel unfamiliar or uneasy employing alternative pharmacological or interventional strategies when faced with such cases. Our expert panel, comprising psychiatry-trained palliative care physicians and a palliative care pharmacist, will adopt a case-based approach to explore different strategies for managing resistant depression within the palliative care setting

This microlearning education presents strategies for managing depression resistant to first-line treatment providing palliative care providers with diverse pharmacological and interventional options beyond SSRIs. This activity is presented in 4 microlearning flights to support short learning bursts of education addressing depression that does not respond to an initial medication trial among palliative care.

Target Audience

Hospice Medical Directors
HPM Physicians
Nurses
Nurse Practitioners
Pharmacists
PAs 

Learning Outcomes

Using a case-based approach, learners will apply, analyze, and evaluate:
• depression among palliative care patients that does not respond to an initial medication trial.
• high-yield pharmacological and interventional second-line approaches to care and treatment of refractory depression. 

Activity summary
Available credit: 
  • 1.25 ABIM MOC
  • 1.25 ABS MOC
  • 1.25 CME (physician only)
  • 1.25 Participation
Activity Published: 
06/24/2024
Activity Expires: 
06/30/2027
Member cost:
$45.00
List Price:
$60.00
Rating: 
0

Disclosures 
AAHPM endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for disclosure and commercial support and endeavors to ensure balance, independence, objectivity, and scientific rigor for all accredited products or programs. All who are in a position to control or influence the content of an educational activity must disclose any relevant financial relationships with ineligible companies.*Disclosure documents were reviewed for potential conflicts of interest and, if identified, were resolved prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.

All editors, faculty and staff have disclosed no relevant financial relationships.

*An ineligible company is defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients. 

Faculty
Daniel Shalev, MD
Paul Noufi, MD
Joshua Borris, PharmD MS BCGP
Gregg Robbins-Welty, MD MS HEC-C

Staff
Leah Farfan, BA
Liz Watson, BA
Rebecca Wyant, BS
Julie Tanner, BSN RN-BC CHPN
Theresa Nissen, BA
Laura Witt, MS-HSM
Julie Bruno, MSW LCSW

Continuing Medical Education (CME)
The American Academy of Hospice and Palliative Medicine (AAHPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Academy of Hospice and Palliative Medicine (AAHPM) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion includes attesting to meaningful activity participation and completion/submission of activity evaluation within the time frame designated.

Evaluation period closes June 30, 2027 at 11:59pm CT for claiming CME credit.

Maintenance of Certification (MOC) Recognition Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Management of Depression Refractory to First-Line Therapies Micro-Learning Flight apply toward general CME requirement) for the following ABMS Member Boards:

• Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
• Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit. By submitting your evaluation, you grant AAHPM permission to submit completion information to ACCME for the purpose of granting respective BOARD MOC program credit or points as applicable.

Evaluation period closes June 30, 2027 at 11:59pm CT for claiming MOC credits.

Available Credit

  • 1.25 ABIM MOC
  • 1.25 ABS MOC
  • 1.25 CME (physician only)
  • 1.25 Participation

Price

Member cost:
$45.00
List Price:
$60.00
Please login or register to take this course.